Merrick I. Ross MD
Breast, Surgical Oncology (Other than Breast)
Professor of Surgery, University Tex Houston
Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Are you Dr. Ross?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Merrick Ross, MD is a general surgeon in Houston, Texas. He is currently licensed to practice medicine in Texas, Alabama, and Alabama. He is a Professor of Surgery at University Tex Houston.
Education & Training
University of Texas Health Science Center at HoustonResidency, Surgery, 1987 - 1989
University of Illinois College of Medicine at ChicagoResidency, Surgery, 1984 - 1987
Scripps Clinic/Scripps Green HospitalFellowship, Allergy and Immunology, 1982 - 1983- University of Illinois College of Medicine at ChicagoResidency, Surgery, 1980 - 1982
- University of Illinois College of MedicineClass of 1980
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2027
GA State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
AL State Medical License 2023 - 2025- AL State Medical License 2023 - 2025
LA State Medical License 2023 - 2025
American Board of Surgery Surgery- Join now to see all
Publications & Presentations
PubMed
- Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Primary Tumor Location in the Randomized, Double-Blind, Phase III KEYNOTE-716 Trial.Charles H Yoon, Merrick I Ross, Brian R Gastman, Jason J Luke, Paolo A Ascierto
Annals of Surgical Oncology. 2025-04-01 - Durable local control with hypofractionated radiation therapy for unresectable or metastatic melanoma.Sydney A Keatts, Aya F Salem, David M Swanson, Ahsan S Farooqi, Andrew J Bishop
Clinical and Translational Radiation Oncology. 2024-11-01 - 13 citationsNCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024.Susan M Swetter, Douglas Johnson, Mark R Albertini, Christopher A Barker, Sarah Bateni
Journal of the National Comprehensive Cancer Network. 2024-07-01
Press Mentions
Predicting the Risk of Relapse in Early-Stage MelanomaAugust 12th, 2024- What Happened to Melanoma Care During COVID-19 SequestrationNovember 11th, 2020
- Non-Hodgkin Lymphoma Caregiver: MD Anderson Saved Me and My HusbandJuly 28th, 2020
- Join now to see all
